The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
DNAJB1-PRKACA fusions occur in oncocytic pancreatic and biliary neoplasms and are not specific for fibrolamellar hepatocellular carcinoma
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Like other tumorigenic transcriptomes that result in a fully active PKA-C, it is likely that alterations in the allosteric network impart defective binding cooperativity and may play a role in their aberrant functions35,36,53.”
From Defective internal allosteric network imparts dysfunctional ATP/substrate-binding cooperativity in oncogenic chimera of protein kinase A (2021) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160
Zehir, A., Benayed, R., Shah, R. H., Syed, A., Middha, S., Kim, H. R., Srinivasan, P., Gao, J., Chakravarty, D., Devlin, S. M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4333 · Cited by 3,380
Self-citationTomasini, M. D., Wang, Y., Karamafrooz, A., Li, G., Beuming, T., Gao, J., Taylor, S. S., Veglia, G., & Simon, S. M. (2018) · Scientific Reports · doi:10.1038/s41598-017-18956-w · Cited by 30
Research works printed but not linked: 33
- Honeyman, 2014, Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma, Science, 343, 1010, 10.1126/science.1249484 · DOI · Paper page
- Graham, 2015, DNAJB1-PRKACA is specific for fibrolamellar carcinoma, Mod Pathol, 28, 822, 10.1038/modpathol.2015.4 · DOI · Paper page
- Simon, 2015, Transcriptomic characterization of fibrolamellar hepatocellular carcinoma, Proc Natl Acad Sci USA, 112, E5916, 10.1073/pnas.1424894112 · DOI · Paper page
- Graham, 2018, Fibrolamellar Carcinoma: what is new and why it matters, Surg Pathol Clin, 11, 377, 10.1016/j.path.2018.02.006 · DOI
- Adsay, 1996, Intraductal oncocytic papillary neoplasms of the pancreas, Am J Surg Pathol, 20, 980, 10.1097/00000478-199608000-00007 · DOI · Paper page
- Basturk, 2016, The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes, Mod Pathol, 29, 1058, 10.1038/modpathol.2016.98 · DOI
- Wang, 2019, Intraductal oncocytic papillary neoplasms: clinical-pathologic characterization of 24 cases, with an emphasis on associated invasive carcinomas, Am J Surg Pathol, 43, 656, 10.1097/PAS.0000000000001226 · DOI
- Wang, 2018, Mass-forming intraductal neoplasms of the biliary tract comprise morphologically and genetically distinct entities (abstract), Mod Pathol, 31, 1927A
- Cheng, 2015, Memorial sloan kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology, J Mol Diagn, 17, 251, 10.1016/j.jmoldx.2014.12.006 · DOI · Paper page
- Middha S, Zhang L, Nafa K, Jayakumaran G, Wong D, Kim HR, et al. Reliable Pan-Cancer Microsatellite Instability Assessment by Using Targeted Next-Generation Sequencing Data. JCO Precis Oncol. 2017;2017. https://doi.org/10.1200/PO.17.00084. · DOI · Paper page
- Shen, 2016, FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing, Nucleic Acids Res, 44, e131, 10.1093/nar/gkw520 · DOI · Paper page
- Zheng, 2014, Anchored multiplex PCR for targeted next-generation sequencing, Nat Med, 20, 1479, 10.1038/nm.3729 · DOI · Paper page
- Benayed, 2019, High yield of RNA sequencing for targetable kinase fusions in lung adenocarcinomas with no mitogenic driver alteration detected by DNA sequencing and low tumor mutation burden, Clin Cancer Res, 25, 4712, 10.1158/1078-0432.CCR-19-0225 · DOI · Paper page
- Askan, 2016, Expression of markers of hepatocellular differentiation in pancreatic acinar cell neoplasms: a potential diagnostic pitfall, Am J Clin Pathol, 146, 163, 10.1093/ajcp/aqw096 · doi:10.1093/ajcp/aqw096
- Reid, 2016, The DNAJB1-PRKACA chimera: candidate biomarker and therapeutic target for fibrolamellar carcinomas, Hepatology, 63, 662, 10.1002/hep.28307 · DOI
- Xu, 2015, Genomic analysis of fibrolamellar hepatocellular carcinoma, Hum Mol Genet, 24, 50, 10.1093/hmg/ddu418 · DOI · Paper page
- Engelholm, 2017, CRISPR/Cas9 engineering of adult mouse liver demonstrates that the Dnajb1-Prkaca gene fusion is sufficient to induce tumors resembling fibrolamellar hepatocellular carcinoma, Gastroenterology, 153, 1662, 10.1053/j.gastro.2017.09.008 · DOI
- Kastenhuber, 2017, DNAJB1-PRKACA fusion kinase interacts with beta-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma, Proc Natl Acad Sci USA, 114, 13076, 10.1073/pnas.1716483114 · DOI · Paper page
- Dinh, 2019, MicroRNA-375 suppresses the growth and invasion of fibrolamellar carcinoma, Cell Mol Gastroenterol Hepatol, 7, 803, 10.1016/j.jcmgh.2019.01.008 · DOI
- Graham, 2016, FGFR1 and FGFR2 in fibrolamellar carcinoma, Histopathology, 68, 686, 10.1111/his.12799 · doi:10.1111/his.12799
- Graham, 2018, Fibrolamellar carcinoma in the carney complex: PRKAR1A loss instead of the classic DNAJB1-PRKACA fusion, Hepatology, 68, 1441, 10.1002/hep.29719 · DOI · Paper page
- Nakamura, 2015, Genomic spectra of biliary tract cancer, Nat Genet, 47, 1003, 10.1038/ng.3375 · DOI · Paper page
- Shibata, 2018, Molecular genomic landscapes of hepatobiliary cancer, Cancer Sci, 109, 1282, 10.1111/cas.13582 · DOI · Paper page
- Drilon, 2018, Response to ERBB3-Directed targeted therapy in NRG1-rearranged cancers, Cancer Disco, 8, 686, 10.1158/2159-8290.CD-17-1004 · DOI · Paper page
- Reid, 2016, Cytopathologic diagnosis of oncocytic type intraductal papillary mucinous neoplasm: Criteria and clinical implications of accurate diagnosis, Cancer Cytopathol, 124, 122, 10.1002/cncy.21627 · DOI
- Farhi, 1982, Ultrastructure of fibrolamellar oncocytic hepatoma, Cancer, 50, 702, 10.1002/1097-0142(19820815)50:4<702::AID-CNCR2820500414>3.0.CO;2-F · doi:10.1002/1097-0142(19820815)50:4<702::aid-cncr2820500414>3.0.co;2-f
- Thomson, 2002, Evidence of undiscovered cell regulatory mechanisms: phosphoproteins and protein kinases in mitochondria, Cell Mol Life Sci, 59, 213, 10.1007/s00018-002-8417-7 · DOI
- Ward, 2010, Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation, Mod Pathol, 23, 1180, 10.1038/modpathol.2010.105 · doi:10.1038/modpathol.2010.105
- Lin, 2018, Fibrolamellar Carcinoma: a concise review, Arch Pathol Lab Med, 142, 1141, 10.5858/arpa.2017-0083-RS · doi:10.5858/arpa.2017-0083-rs
- Basturk, 2016, Distinct pathways of pathogenesis of intraductal oncocytic papillary neoplasms and intraductal papillary mucinous neoplasms of the pancreas, Virchows Arch, 469, 523, 10.1007/s00428-016-2014-x · DOI
- Martin, 2002, Hepatic intraductal oncocytic papillary carcinoma, Cancer, 95, 2180, 10.1002/cncr.10934 · doi:10.1002/cncr.10934
- Lalazar, 2018, Fibrolamellar carcinoma: recent advances and unresolved questions on the molecular mechanisms, Semin Liver Dis, 38, 51, 10.1055/s-0037-1621710 · DOI · Paper page
- Kastenhuber, 2019, Road map for fibrolamellar carcinoma: progress and goals of a diversified approach, J Hepatocell Carcinoma, 6, 41, 10.2147/JHC.S194764 · DOI
Cited by
Early detection of pancreatic cancer using DNA-based molecular approaches
Singhi, A. D., & Wood, L. D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00470-0 · Cited by 127
Olivieri, C., Walker, C., Karamafrooz, A., Wang, Y., Manu, V. S., Porcelli, F., Blumenthal, D. K., Thomas, D. D., Bernlohr, D. A., Simon, S. M., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-01819-6 · Cited by 27
Gritti, I., Wan, J., Weeresekara, V., Vaz, J. M., Tarantino, G., Bryde, T. H., Vijay, V., Kammula, A. V., Kattel, P., Zhu, S., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0634 · Cited by 20
Metadata
- Authors
- Vyas, M., Hechtman, J. F., Zhang, Y., Benayed, R., Yavas, A., Askan, G., Shia, J., Klimstra, D. S., & Basturk, O.
- Venue
- Modern Pathology
- Publisher
- Elsevier BV
- Published
- 2020-04
- Volume
- 33
- Issue
- 4
- Pages
- 648-656
- ISSN
- 0893-3952
- Cited by
- 127
- References
- 4
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 1015 d)
- Funders
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30-CA008748)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: DNAJB1-PRKACA fusions occur in oncocytic pancreatic and biliary neoplasms and are not specific for fibrolamellar hepatocellular carcinoma. https://app.cochat.ai/papers/10.1038/s41379-019-0398-2
- The paper
- Vyas, M., Hechtman, J. F., Zhang, Y., Benayed, R., Yavas, A., Askan, G., Shia, J., Klimstra, D. S., & Basturk, O. (2020). DNAJB1-PRKACA fusions occur in oncocytic pancreatic and biliary neoplasms and are not specific for fibrolamellar hepatocellular carcinoma. Modern Pathology. https://doi.org/10.1038/s41379-019-0398-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.